Thanks, Bryan. Everyone can follow along on the chart presentation. We will start on Page 3, where we have the overall financial highlights for the first quarter. As you can see, we had a great quarter for orders with an increase of 28%, which resulted in record backlog of $848 million. The A&D businesses led the order growth which resulted in a first quarter consolidated book-to-bill ratio of 1.35. Sales in the quarter were up over 6% which was comprised of 4% organic growth and a 2% impact from the CMT and MPE acquisitions. Adjusted EBIT was up 7.5%, adjusted EBITDA up over 7% and adjusted earnings per share up 3% in the quarter. Adjusted EBITDA margins increased by 20 basis points as increases from the A&D businesses were offset by declines from Test and Utility group. Moving to Chart 4, we'll start with segment details. First with Aerospace & Defense, we really got off to a strong start here which was great to see, beginning with orders we achieved a 1.8 book-to-bill ratio as the Navy business received large orders on the Virginia Class submarine program This resulted in backlog of more than 560 million at December 31st, a record amount for this business. Moving on to sales, overall growth was 14%, which was comprised of 10% organic growth and four additional points of growth from the CMT acquisition. The sales growth was led by strength from the commercial and defense aerospace, as well as the Navy business. Adjusted EBITDA margins in the quarter increased by 230 basis points as we saw nice leverage on the sales growth and favorable impacts from price, which were only partially offset by inflation and mix. On Chart 5, we have the Utility Solutions Group. Here we delivered another great quarter for ESCO. Orders were down in the quarter, which Bryan mentioned, this was driven by modest reductions at NRG. The renewables business saw exceptional order growth through June 30th of last year, a strong industry dynamics and government incentive programs spurred customer orders. Since then, the order pace has moderated and the business has burned down backlog. Currently, we are starting to see increasing order pipeline activity in the renewables business, and we do expect to see order growth return as we move forward. On the sales side for USG, we had an increase of 17% in the first quarter and we had double-digit growth for both Doble and NRG. Adjusted EBITDA dollars increased by more than 10%, while the margins declined 150 basis points. We did see favorable impacts from volume growth and price during the quarter, but they were more than offset by unfavorable mix and inflationary pressures. Next, we'll go to Chart 6 and the Test business where we had orders decreased by 12% compared to last year's first quarter. This was driven by lower orders in the U.S and some timing of getting new orders booked in China and Europe. On the sales line, we saw a reduction of 21%. All world areas experienced sales declines with the largest reduction coming in the U.S. Bryan mentioned this above, but we are seeing some delays in the U.S with getting projects executed and that has caused U.S sales to be lower than planned in the first two quarters of fiscal 2024. Adjusted EBITDA margins declined to 8.3% in the quarter as we significantly deleveraged on the sales volume drop and also experienced unfavorable mix. We are executing a plan to take cost out of this business and expect to see sales and profitability trends improve as we get into the second half of the year. Next is Chart 7 where we have the cash flow highlights. We did have a positive swing in the first quarter. Cash flow as a cash use of $9 million in the first quarter last year, swung to a positive cash flow of $9 million in this year's quarter. We saw favorable impacts in working capital from improved net contract assets as well as favorability from accounts payable and accrued expenses when compared to last year's first quarter. Capital spending in the quarter did increase driven by investments from the Aerospace & Defense business. You can also see here where the MPE acquisition was just over $56 million and we had no share repurchases completed during the first quarter. The last chart today is #8, which is our updated 2024 guidance. The outlook for ESCO remains strong. Starting with earnings, we are still tracking to deliver the adjusted earnings per share range that was communicated back in November. In fact, we have increased the bottom of the range from $4.10 to $4.15, and we have an overall range of $4.15 to $4.30 per share, which represents growth in a range of 12% to 16%. For sales, we expect an increase for the year in the range of 7% to 9%. The overall sales growth range is consistent with what we communicated in November, but we have seen some movement by business. We now expect the Aerospace & Defense group to grow in a range of 11% to 13%. We had communicated 8% to 10% for this business initially, but with a strong start to the first quarter and continued orders momentum, we have now increased this outlook. For the Utility Group, the sales growth range is 6% to 8%. This is the same as what we communicated in November. And lastly, for Test, the range has dropped and we now expect growth in a range of 1% to 3%. The slower first half in project delays mentioned previously have reduced the growth outlook here. The Test range does include the impact of the MPE acquisition. For the second quarter, we expect adjusted earnings per share in a range of $0.85 to $0.90, which would represent growth in a range of 12% to 18% over last year's second quarter. That concludes the financial update and now I'll turn it back over to Bryan.